N. Thorintrescases et al., SIGNAL-TRANSDUCTION MECHANISMS OF THE VASOCONSTRICTION IN HYPERTENSION, European journal of pharmacology. Molecular pharmacology section, 268(2), 1994, pp. 199-207
We tested the hypothesis that vascular smooth muscle in genetic hypert
ension is characterised by hypereactivity to vasoactive agonists, by a
bnormalities in Ca2+ handling and the phosphoinositide signalling syst
em. Activation of these signal transduction mechanisms by noradrenalin
e and endothelin-1 was compared in isolated perfused tail arteries fro
m adult hypertensive and normotensive Wistar Kyoto rats. Basal cytosol
ic Ca2+ was greater in arteries from hypertensive rats, but basal perf
usion pressure and basal inositol phosphate accumulation were unchange
d. Contractile responses and Ca2+ mobilisation after noradrenaline, bu
t not endothelin-1, were enhanced in arteries from hypertensive rats.
Total inositol phosphates accumulation was similar in hypertensive and
normotensive rats after either noradrenaline or endothelin-1 stimulat
ion. In both hypertensive and normotensive rats, for a given Ca2+ mobi
lisation, higher contractile responses and higher levels of inositol p
hosphates were observed after endothelin-1 than noradrenaline stimulat
ion. In conclusion, changes in contractility associated with modificat
ions in the Ca2+ handling between hypertensive and normotensive rats s
uggested that alterations in the signal-transduction system occur with
hypertension. The different effects of endothelin-1 and noradrenaline
could be related to interactions with other signalling pathways.